Table 2 Details of the disease stage, chemotherapy treatment and disease outcome of the 11 rectal cancer patients of our validation cohort
Patient | Stage | Neo-adjuvant therpay | RCPATH | Outcome |
|---|---|---|---|---|
1 | III | 50.4/28 + 5FU | A | Good |
2 | III | 54.0/30 + 5FU | A | Good |
3 | III | 50.4/28 + 5FU | A | Good |
4 | II | 50.4/28 + 5FU | A | Good |
5 | III | 50.4/28 + 5FU | B | Poor |
6 | III | 50.4/28 + 5FU | B | Poor |
7 | III | 50.4/28 + 5FU | B | Poor |
8 | III | 50.4/28 + 5FU | B | Poor |
9 | III | 50.4/28 + 5FU | C | Poor |
10 | III | 50.4/28 + 5FU | C | Poor |
11 | II | 50.4/28 + 5FU | C | Poor |